@article{Dong2026, 
author = {Jia-Hong Dong and Nan Jiang and Shuo Jin and Yin-Zhe Xu and Tian Yang and Timothy M. Pawlik and Si-Qiao Shan and Dong-Liang Yang and Jian-Ping Zeng and Can-Hong Xiang},
title = {Surgery-oriented classification and treatment strategy for adult congenital biliary dilatation},
year = {2026},
journal = {iLIVER},
volume = {5},
number = {2},
keywords = {Classification, Surgery, Precision surgery, Biliary tract disease, Congenital biliary dilatation},
url = {https://www.sciopen.com/article/10.1016/j.iliver.2026.100238},
doi = {10.1016/j.iliver.2026.100238},
abstract = {Background and aimsManagement of adult congenital biliary dilatation (CBD) lacks standardized surgical guidance, particularly for complex intrahepatic and intrapancreatic involvement. Traditional anatomical classifications inadequately address modern surgical decision-making needs. This study aimed to develop and validate a surgery-oriented classification system that guides precise surgical approaches for adult CBD.MethodsA classification system was developed based on anatomical characteristics, disease extent, and corresponding surgical approaches in 234 patients with CBD. Surgical procedures guided by the classification system included hepatectomy, biliary reconstruction, and liver transplantation. The long-term surgical outcomes and perioperative complications were analyzed.ResultsThe classification system categorized 234 patients with CBD into the following 4 types with 2 subtypes: Type A-peripheral intrahepatic (12 patients [5.1%]), Type B-central intrahepatic (5 [2.1%]), Type C-extrahepatic (45 [19.2%]), and Type D-combined intra- and extrahepatic (172 [73.5%]). Classification-guided surgery achieved excellent and good outcomes in 84.5% of cases. Major complications (Clavien–Dindo grade ≥ Ⅲ) occurred in 33 (14.1%) patients. Three-year disease-free survival was 71.4%, 100.0%, 89.3%, and 63.0% for Types A to D, respectively (p = 0.026). Type D2 patients, defined as having the most complex disease patterns, had the worst outcomes (3-year disease-free survival: 61.6%).ConclusionsOur surgery-oriented classification effectively stratified adult CBD and guided the selection of surgical approaches. It shows particular value in managing complex disease patterns, although patients with combined intra- and extrahepatic involvement require careful consideration relative to the extent of surgical management. The standardized approach and validated outcomes of this classification suggest potential for widespread adoption in global surgical practice.}
}